Literature DB >> 3140913

A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X.

P Neuenschwander1, J Jesty.   

Abstract

Two aspects of the activation of factor X by the intrinsic clotting pathway have been studied in purified human systems, in the presence of either purified phosphatidylserine:phosphatidylcholine vesicles (PS:PC) or platelets activated with ionophore A23187: (1) the activation of factor VIII by factor Xa and by thrombin, and (2) the activation of factor X by the factor IXa/VIIIa complex. Factor VIII activation by thrombin was unaffected in either rate or extent by the presence of PS:PC or activated platelets. In contrast, factor VIII activation by factor Xa required either PS:PC or platelets. The products of optimal factor VIII activation by the two enzymes, designated factor VIIIa(T) and factor VIIIa(Xa), are kinetically different in the activation of factor X by factor IXa, factor VIIIa(T) being approximately twice as active (in factor X activation) as factor VIIIa(Xa) in the presence of PS:PC or platelets. Factor VIIIa(Xa) can be converted to the more active VIIIa(T) by thrombin treatment, but the activity of factor VIIIa(T) is unchanged by factor Xa treatment. Factor X activation was also studied with optimally activated factor VIIIa(T), in the presence of PS:PC or activated platelets, as a function of factor IXa concentration in order to determine the apparent dissociation constant for the factor IXa-VIIIa interaction in the two cases. Activated platelets increased the apparent affinity more than fivefold.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140913

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.

Authors:  S S Ahmad; R Rawala-Sheikh; B Ashby; P N Walsh
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

3.  A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.

Authors:  Kathryn G Link; Michael T Stobb; Matthew G Sorrells; Maria Bortot; Katherine Ruegg; Marilyn J Manco-Johnson; Jorge A Di Paola; Suzanne S Sindi; Aaron L Fogelson; Karin Leiderman; Keith B Neeves
Journal:  J Thromb Haemost       Date:  2019-11-01       Impact factor: 5.824

4.  Routine clinical anti-platelet agents have limited efficacy in modulating hypershear-mediated platelet activation associated with mechanical circulatory support.

Authors:  Lorenzo Valerio; Jawaad Sheriff; Phat L Tran; William Brengle; Alberto Redaelli; Gianfranco B Fiore; Federico Pappalardo; Danny Bluestein; Marvin J Slepian
Journal:  Thromb Res       Date:  2017-12-05       Impact factor: 3.944

5.  Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.

Authors:  D Repke; C H Gemmell; A Guha; V T Turitto; G J Broze; Y Nemerson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.

Authors:  S Gillis; B C Furie; B Furie; H Patel; M C Huberty; M Switzer; W B Foster; H A Scoble; M D Bond
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

7.  Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.

Authors:  Karin Leiderman; William C Chang; Mikhail Ovanesov; Aaron L Fogelson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-27       Impact factor: 8.311

8.  Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.

Authors:  Manash S Chatterjee; William S Denney; Huiyan Jing; Scott L Diamond
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

9.  Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

Authors:  Mikhail A Panteleev; Evgueni L Saenko; Natalya M Ananyeva; Fazoil I Ataullakhanov
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

10.  Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices.

Authors:  Lorenzo Valerio; Phat L Tran; Jawaad Sheriff; William Brengle; Ram Ghosh; Wei-Che Chiu; Alberto Redaelli; Gianfranco B Fiore; Federico Pappalardo; Danny Bluestein; Marvin J Slepian
Journal:  Thromb Res       Date:  2016-02-01       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.